OUR GOAL IS TO HELP OVERCOME CHALLENGES

Advocate for targeted regulatory reforms that facilitate access to unlicensed medicines, aligned with leading European practices:

• Develop educational programs tailored to healthcare professionals, hospital administrators, and relevant stakeholders
• Organize specialized forums to share up-to-date information and strengthen legal and procedural awareness within the sector
• Establish the Association as a trusted partner for institutions in shaping policy on rare diseases and access to unapproved treatments

Ensuring equitable access to healthcare requires coordinated efforts from institutions, healthcare providers, and society as a whole.

As a company dedicated to sustainable healthcare solutions, Reimex Pharma remains firmly committed to supporting initiatives that create accessible, informed, and effective care across Bulgaria and beyond.

Read the full article (in Bulgarian) on Capital.bg: Предизвикателства и решения при достъпа до нерегистрирани лекарствени продукти в България